Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Sufentanil for Analgesia After Cesarean Section
NCT02604797Unknown
- Sponsor
- Fudan University
- Start
- Jan 2016
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
01
Overview
Trial of nalbuphine in postoperative pain (2 arms), sponsored by Fudan University. Primary endpoint: Pain scores up to 24 months. Status: unknown.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02604797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02604797.